文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

急性呼吸窘迫综合征的死腔通气指数与死亡率:系统评价与Meta分析

Dead-Space Ventilation Indices and Mortality in Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis.
PubMed 文献 · Crit Care Med · 2023-05-19
一句话结论在成人ARDS中,高肺死腔分数和高通气比值均独立与死亡率增加相关,这些指数可用于临床试验和识别可能从早期辅助治疗中获益的患者。

该系统评价与Meta分析纳入28项研究(其中21项进入Meta分析),评估死腔通气指标对成人ARDS患者死亡率的预测能力。结果显示,高肺死腔分数与死亡率增加相关(OR 3.52,95%CI 2.22-5.58,p<0.001,I²=84%);校正混杂因素后,肺死腔分数每增加0.05,死亡比值增加(OR 1.23,95%CI 1.13-1.34,p<0.001,I²=57%)。高通气比值也与死亡率增加相关(OR 1.55,95%CI 1.33-1.80,p<0.001,I²=48%),且独立于常见混杂因素(OR 1.33,95%CI 1.12-1.58,p=0.001,I²=66%)。作者认为这些指数可纳入临床试验并用于识别可能从早期辅助治疗中获益的患者,但本研究所确定的截断值应进行前瞻性验证。

要点

  • 高肺死腔分数与成人ARDS患者死亡率增加相关(OR 3.52,95%CI 2.22-5.58,p<0.001,I²=84%)。
  • 校正混杂因素后,肺死腔分数每增加0.05,死亡比值增加(OR 1.23,95%CI 1.13-1.34,p<0.001,I²=57%)。
  • 高通气比值与死亡率增加相关(OR 1.55,95%CI 1.33-1.80,p<0.001,I²=48%),校正后仍独立相关(OR 1.33,95%CI 1.12-1.58,p=0.001,I²=66%)。
  • 作者认为死腔通气指数可纳入临床试验并用于识别可能从早期辅助治疗中获益的患者。
  • 本研究所确定的截断值应进行前瞻性验证。

适用人群与场景

  • 成人急性呼吸窘迫综合征(ARDS)患者。

研究设计与关键结果

  • 系统评价与Meta分析,纳入28项研究,其中21项进入Meta分析;所有研究偏倚风险低。
  • 高肺死腔分数与死亡率增加相关(OR 3.52,95%CI 2.22-5.58,p<0.001,I²=84%)。
  • 校正其他混杂变量后,肺死腔分数每增加0.05,死亡比值增加(OR 1.23,95%CI 1.13-1.34,p<0.001,I²=57%)。
  • 高通气比值与死亡率增加相关(OR 1.55,95%CI 1.33-1.80,p<0.001,I²=48%)。
  • 校正常见混杂变量后,通气比值与死亡率的相关性独立(OR 1.33,95%CI 1.12-1.58,p=0.001,I²=66%)。

证据类型、等级与局限

  • 系统评价与Meta分析,采用随机效应模型计算合并效应估计,使用Quality in Prognostic Studies评估质量,使用GRADE评估证据强度;所有研究偏倚风险低。
  • 局限:本研究所确定的截断值应进行前瞻性验证。

对床旁实践的改变

  • 作者认为死腔通气指数可纳入临床试验,并用于识别可能从早期辅助治疗中获益的ARDS患者。
  • 本研究所确定的截断值应进行前瞻性验证。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Acute respiratory distress syndrome (ARDS) is associated with high ventilation-perfusion heterogeneity and dead-space ventilation. However, whether the degree of dead-space ventilation is associated with outcomes is uncertain. In this systematic review and meta-analysis, we evaluated the ability of dead-space ventilation measures to predict mortality in patients with ARDS.

DATA SOURCES: MEDLINE, CENTRAL, and Google Scholar from inception to November 2022.

STUDY SELECTION: Studies including adults with ARDS reporting a dead-space ventilation index and mortality.

DATA EXTRACTION: Two reviewers independently identified eligible studies and extracted data. We calculated pooled effect estimates using a random effects model for both adjusted and unadjusted results. The quality and strength of evidence were assessed using the Quality in Prognostic Studies and Grading of Recommendations, Assessment, Development, and Evaluation, respectively.

DATA SYNTHESIS: We included 28 studies in our review, 21 of which were included in our meta-analysis. All studies had a low risk of bias. A high pulmonary dead-space fraction was associated with increased mortality (odds ratio [OR], 3.52; 95% CI, 2.22-5.58; p < 0.001; I2 = 84%). After adjusting for other confounding variables, every 0.05 increase in pulmonary-dead space fraction was associated with an increased odds of death (OR, 1.23; 95% CI, 1.13-1.34; p < 0.001; I2 = 57%). A high ventilatory ratio was also associated with increased mortality (OR, 1.55; 95% CI, 1.33-1.80; p < 0.001; I2 = 48%). This association was independent of common confounding variables (OR, 1.33; 95% CI, 1.12-1.58; p = 0.001; I2 = 66%).

CONCLUSIONS: Dead-space ventilation indices were independently associated with mortality in adults with ARDS. These indices could be incorporated into clinical trials and used to identify patients who could benefit from early institution of adjunctive therapies. The cut-offs identified in this study should be prospectively validated.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Jayasimhan D, Chieng J, Kolbe J, et al. Dead-Space Ventilation Indices and Mortality in Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis. Crit Care Med. 2023. PMID: 37204257. doi:10.1097/CCM.0000000000005921

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。